Avoid common mistakes on your manuscript.
We thank Luque-Paz and colleagues [1] for their interest in our editorial [2]. We respectfully differ from their overly conservative perspective. We certainly are not advocating for microbiologist redundancy but we would encourage the infectious disease community to rapidly embrace new technologies that will enhance their speciality and patient care, albeit with the necessary caveats regarding validation and safety. Only a decade or so ago, echocardiography was the sole domain of cardiologists and a limited and often delayed resource. It is now ubiquitous in critical care units and available around the clock, yet input from the specialist cardiologist remains integral for complex cases. AI and rapid or even point-of-care diagnostics should be similarly viewed as opportunity for the microbiologist rather than threat. Most hospitals around Europe only offer Matrix Assisted Laser Desorption Ionization—Time of Flight (MALDI-TOF) technology in conventional working hours and it is often employed only once standard cultures yielded positive results, a process that usually spans a day or more. Would not the critically ill patient benefit from rapid pathogen identification in the middle of the night with, perhaps more importantly, identification of antimicrobial susceptibility patterns that allow focused treatment and immediate antimicrobial stewardship augmented by AI? Such technologies are arriving that will give results within hours rather than days [3]. Carpe diem!
Data availability
Not applicable.
References
Luque-Paz D, Turban A, Tattevin P, Cattoir V (2023) 2030: the need for microbiologists and antimicrobial stewardship teams will still remain paramount. Intensive Care Med. https://doi.org/10.1007/s00134-023-07221-6
Lakbar I, Singer M, Leone M (2023) 2030: will we still need our microbiologist? Intensive Care Med. https://doi.org/10.1007/s00134-023-07186-6
Banerjee R, Humphries R (2021) Rapid antimicrobial susceptibility testing methods for blood cultures and their clinical impact. Front Med. https://doi.org/10.3389/fmed.2021.635831
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
ML reports receiving consulting fees from LFB, Viatris, AOP. MS reports receiving consulting fees from DeepUll, Aptarion, Pfizer, Roche Diagnostics and Safeguard Biosystems. No conflict of interest is reported for IL.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available online at https://doi.org/10.1007/s00134-023-07186-6.
Rights and permissions
About this article
Cite this article
Lakbar, I., Singer, M. & Leone, M. 2030: The need for microbiologists and antimicrobial stewardship teams will still remain paramount. Author’s reply. Intensive Care Med 49, 1435 (2023). https://doi.org/10.1007/s00134-023-07230-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-023-07230-5